Showing results (141-150 of 382) with videos related to

Sort By:
Pageof 39
The Prostate|October 23, 2018
A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growthShu-Han Yu, Janielle P Maynard, Ajay M Vaghasia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cellsMichelle A Hurchla, John R Sedy, Maya Gavrieli, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder CancerNiv Milbar, Max Kates, Meera R Chappidi, et al.
Urology|January 21, 2017
Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder CancerMeera R Chappidi, Max Kates, Aaron Brant, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 17, 2014
Comorbidities and causes of death in the management of localized T1a kidney cancerHiten D Patel, Max Kates, Phillip M Pierorazio, et al.
The Canadian Journal of Urology|August 22, 2016
Infectious complications in transfused patients after radical cystectomyJen-Jane Liu, Patrick Mullane, Max Kates, et al.
The Journal of Sexual Medicine|July 16, 2017
Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive FactorsFilippo Pederzoli, Meera R Chappidi, Sarah Collica, et al.
Oncoimmunology|May 3, 2014
Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomideSusannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, et al.
Cancer Immunology Research|February 27, 2021
Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor ModelCasey R Ager, Aleksandar Z Obradovic, Juan M Arriaga, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2018
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarizationTheresa Barberi, Allison Martin, Rahul Suresh, et al.
Pageof 39